FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386726110> ?p ?o ?g. }

• W4386726110 abstract "Octadentate and specifically nonadentate ligands with a bispidine scaffold (3,7-diazabicyclo[3.3.1]nonane) are known to be efficiently coordinated to a range of metal ions of interest in radiopharmaceutical chemistry and lead to exceedingly stable and inert complexes. Nonadentate bispidine L2 (with a tridentate bipyridine acetate appended to N3 and a picolinate at N7) has been shown before to be an ideal chelator for 111In3+, 177Lu3+, and 225Ac3+, nuclides of interest for diagnosis and therapy, and a proof-of-principle study with an SSTR2-specific octreotate has shown potential for theranostic applications. We now have extended these studies in two directions. First, we present ligand derivative L3, in which the bipyridine acetate is substituted with terpyridine, a softer donor for metal ions with a preference for more covalency. L3 did not fulfill the hopes because complexation is much less efficient. While for Bi3+ and Pb2+ the ligand is an excellent chelator with properties similar to those of L2, Lu3+ and La3+ show very slow and inefficient complexation with L3 in contrast to L2, and 225Ac3+ is not fully coordinated, even at an increased temperature (92% radiochemical yield at 80 °C, 60 min, [L3] = 10-4 M). These observations have led to a hypothesis for the complexation pathway that is in line with all of the experimental data and supported by a preliminary density functional theory analysis, which is important for the design of further optimized bispidine chelators. Second, the coordination chemistry of L2 has been extended to Bi3+, La3+, and Pb2+, including solid state and solution structural work, complex stabilities, radiolabeling, and radiostability studies. All complexes of this ligand (La3+, Ac3+, Lu3+, Bi3+, In3+, and Pb2+), including nuclides for targeted α therapy (TAT), single-photon emission computed tomography, and positron emission tomography, are formed efficiently under physiological conditions, i.e., suitable for the labeling of delicate biological vectors such as antibodies, and the complexes are very stable and inert. Importantly, for TAT with 225Ac, the daughter nuclides 213Bi and 209Pb also form stable complexes, and this is important for reducing damage to healthy tissue." @default.
• W4386726110 created "2023-09-15" @default.
• W4386726110 creator A5010748930 @default.
• W4386726110 creator A5018905339 @default.
• W4386726110 creator A5020231844 @default.
• W4386726110 creator A5033493870 @default.
• W4386726110 creator A5037850236 @default.
• W4386726110 creator A5039612004 @default.
• W4386726110 creator A5040122370 @default.
• W4386726110 creator A5042184078 @default.
• W4386726110 creator A5055224857 @default.
• W4386726110 creator A5070592485 @default.
• W4386726110 creator A5075855211 @default.
• W4386726110 creator A5080929915 @default.
• W4386726110 creator A5085431140 @default.
• W4386726110 creator A5088038796 @default.
• W4386726110 creator A5090423818 @default.
• W4386726110 date "2023-09-14" @default.
• W4386726110 modified "2023-09-26" @default.
• W4386726110 title "Bispidine Chelators for Radiopharmaceutical Applications with Lanthanide, Actinide, and Main Group Metal Ions" @default.
• W4386726110 cites W1557255258 @default.
• W4386726110 cites W185394478 @default.
• W4386726110 cites W1969360633 @default.
• W4386726110 cites W1989223371 @default.
• W4386726110 cites W1989226016 @default.
• W4386726110 cites W1998326947 @default.
• W4386726110 cites W1999339838 @default.
• W4386726110 cites W2007613643 @default.
• W4386726110 cites W2008582198 @default.
• W4386726110 cites W2009046603 @default.
• W4386726110 cites W2018977936 @default.
• W4386726110 cites W2024175762 @default.
• W4386726110 cites W2025159610 @default.
• W4386726110 cites W2041693929 @default.
• W4386726110 cites W2043327592 @default.
• W4386726110 cites W2043504594 @default.
• W4386726110 cites W2055895712 @default.
• W4386726110 cites W2068948738 @default.
• W4386726110 cites W2073490466 @default.
• W4386726110 cites W2082614986 @default.
• W4386726110 cites W2082712943 @default.
• W4386726110 cites W2094100533 @default.
• W4386726110 cites W2096798967 @default.
• W4386726110 cites W2131350133 @default.
• W4386726110 cites W2132454074 @default.
• W4386726110 cites W2138520198 @default.
• W4386726110 cites W2143981217 @default.
• W4386726110 cites W2144332006 @default.
• W4386726110 cites W2148366391 @default.
• W4386726110 cites W2156722259 @default.
• W4386726110 cites W2165528549 @default.
• W4386726110 cites W2166689829 @default.
• W4386726110 cites W2167590372 @default.
• W4386726110 cites W2316959840 @default.
• W4386726110 cites W2328995086 @default.
• W4386726110 cites W2417286343 @default.
• W4386726110 cites W2478447331 @default.
• W4386726110 cites W2745618484 @default.
• W4386726110 cites W2757879990 @default.
• W4386726110 cites W2804699249 @default.
• W4386726110 cites W2808551116 @default.
• W4386726110 cites W2886992763 @default.
• W4386726110 cites W2945870813 @default.
• W4386726110 cites W2977701307 @default.
• W4386726110 cites W2990606648 @default.
• W4386726110 cites W3013167179 @default.
• W4386726110 cites W3038970936 @default.
• W4386726110 cites W3111997102 @default.
• W4386726110 cites W3141292573 @default.
• W4386726110 cites W3148833394 @default.
• W4386726110 cites W3177493668 @default.
• W4386726110 cites W3184579895 @default.
• W4386726110 cites W3190387715 @default.
• W4386726110 cites W4200300212 @default.
• W4386726110 cites W4205389122 @default.
• W4386726110 cites W4206037587 @default.
• W4386726110 cites W4220691813 @default.
• W4386726110 cites W4225147684 @default.
• W4386726110 cites W4281989182 @default.
• W4386726110 cites W4282937028 @default.
• W4386726110 cites W4296613569 @default.
• W4386726110 cites W4309152354 @default.
• W4386726110 cites W4310361310 @default.
• W4386726110 cites W4384820083 @default.
• W4386726110 doi "https://doi.org/10.1021/acs.inorgchem.3c02340" @default.
• W4386726110 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37707798" @default.
• W4386726110 hasPublicationYear "2023" @default.
• W4386726110 type Work @default.
• W4386726110 citedByCount "0" @default.
• W4386726110 crossrefType "journal-article" @default.
• W4386726110 hasAuthorship W4386726110A5010748930 @default.
• W4386726110 hasAuthorship W4386726110A5018905339 @default.
• W4386726110 hasAuthorship W4386726110A5020231844 @default.
• W4386726110 hasAuthorship W4386726110A5033493870 @default.
• W4386726110 hasAuthorship W4386726110A5037850236 @default.
• W4386726110 hasAuthorship W4386726110A5039612004 @default.
• W4386726110 hasAuthorship W4386726110A5040122370 @default.
• W4386726110 hasAuthorship W4386726110A5042184078 @default.
• W4386726110 hasAuthorship W4386726110A5055224857 @default.
• W4386726110 hasAuthorship W4386726110A5070592485 @default.

• next